AEDs Separated From Arrhythmia Detector, Alarms Under Proposed Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA intends to recommend automated external defibrillators (AEDs) for reclassification "at a later time," according to a proposed rule downclassifying arrhythmia detectors and alarms from Class III to Class II with special controls
You may also be interested in...
AED downclassification?
FDA may ask its Circulatory System Devices Panel to discuss the downclassification of automatic external defibrillators to Class II, the agency announces in the Oct. 28 Federal Register. The agency urges stakeholders to submit new safety and efficacy data on AEDs, currently designated Class III devices. A final rule downclassifying arrhythmia detectors and alarms to Class II with special controls, along with an accompanying guidance, also was issued Oct. 28. FDA announced its plans to reclassify arrhythmia detectors and alarms in December 2002, responding to petitions from AdvaMed, Quinton Instrument and Zymed Medical Instrumentation (1"The Gray Sheet" Dec. 23, 2002, p. 24)...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.